William H. Matsui

William Matsui is an Associate Professor in the Department of Oncology at the Johns Hopkins University School of Medicine. He received his A.B. from Harvard University in 1989 where he graduated with honors in Biochemistry, and his M.D. in 1995 from the University of California at San Francisco School of Medicine. He completed his residency training in internal medicine at the University of Washington in Seattle and his clinical fellowship in Medical Oncology at Johns Hopkins. Dr. Matsui is an expert in the development of novel therapeutics in oncology. His research is focused on examining stem cell properties within human cancers and his laboratory first discovered cancer stem cells in multiple myeloma, a cancer of the immune system. Furthermore, Dr. Matsui’s group was the first to demonstrate that the Hedgehog signaling pathway regulates cancer stem cell fate decisions in multiple myeloma, pancreatic carcinoma and acute lymphoblastic leukemia. Dr. Matsui is Board Certified in Internal Medicine and Medical Oncology and clinically specializes in caring for patients with hematologic malignancies that include leukemias, lymphomas, and multiple myeloma. His studies have been instrumental in developing over 12 clinical trials utilizing novel agents in the past 8 years. He has been awarded the George Santos Research Award from the Leukemia and Lymphoma Society, the Clinician Scientist Award from Johns Hopkins University, and teaching awards from the Departments of Oncology and Medicine in the Johns Hopkins University School of Medicine. He has presented and continues to present his work both nationally and internationally. Furthermore, he has served as a consultant for a number of pharmaceutical and biotechnology companies as well as an opinion leader for the financial sector.